[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 992999, "exercisedValue": 0, "unexercisedValue": 1959778}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Dr. Matthew Scott Harris AGAF, FCAP, M.D., MS", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 690737, "exercisedValue": 0, "unexercisedValue": 709666}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 35, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 4, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.87, "open": 3.83, "dayLow": 3.77, "dayHigh": 4.21, "regularMarketPreviousClose": 3.87, "regularMarketOpen": 3.83, "regularMarketDayLow": 3.77, "regularMarketDayHigh": 4.21, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": 0.575, "forwardPE": -2.8014965, "volume": 8407616, "regularMarketVolume": 8407616, "averageVolume": 4861065, "averageVolume10days": 16238400, "averageDailyVolume10Day": 16238400, "bid": 4.08, "ask": 4.14, "bidSize": 5, "askSize": 5, "marketCap": 334014848, "fiftyTwoWeekLow": 2.9, "fiftyTwoWeekHigh": 11.16, "priceToSalesTrailing12Months": 16700.742, "fiftyDayAverage": 5.6656, "twoHundredDayAverage": 6.526725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 165644992, "profitMargins": 0.0, "floatShares": 80428108, "sharesOutstanding": 81107000, "sharesShort": 24400612, "sharesShortPriorMonth": 22671188, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.3008, "heldPercentInsiders": 0.0076099997, "heldPercentInstitutions": 0.47849998, "shortRatio": 8.05, "shortPercentOfFloat": 0.3032, "impliedSharesOutstanding": 81107000, "bookValue": 1.827, "priceToBook": 2.2540777, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -90240000, "trailingEps": -1.26, "forwardEps": -1.47, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 8282.249, "enterpriseToEbitda": -1.69, "52WeekChange": -0.425816, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 4.1182, "targetHighPrice": 28.0, "targetLowPrice": 6.0, "targetMeanPrice": 20.625, "targetMedianPrice": 25.0, "recommendationMean": 1.55556, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 149826000, "totalCashPerShare": 1.847, "ebitda": -98033000, "totalDebt": 1587000, "quickRatio": 15.543, "currentRatio": 15.846, "totalRevenue": 20000, "debtToEquity": 1.116, "revenuePerShare": 0.0, "returnOnAssets": -0.35513002, "returnOnEquity": -0.57277, "grossProfits": -76546000, "freeCashflow": -47675248, "operatingCashflow": -80331000, "revenueGrowth": 0.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4363.0, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1751393720, "shortName": "Altimmune, Inc.", "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "regularMarketChange": 0.24819994, "regularMarketDayRange": "3.77 - 4.21", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 4861065, "fiftyTwoWeekLowChange": 1.2181997, "fiftyTwoWeekLowChangePercent": 0.42006886, "fiftyTwoWeekRange": "2.9 - 11.16", "fiftyTwoWeekHighChange": -7.0418, "fiftyTwoWeekHighChangePercent": -0.6309857, "fiftyTwoWeekChangePercent": -42.5816, "dividendDate": 1536883200, "earningsTimestamp": 1747134002, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1747139400, "earningsCallTimestampEnd": 1747139400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.26, "epsForward": -1.47, "epsCurrentYear": -1.2656, "priceEpsCurrentYear": -3.2539506, "fiftyDayAverageChange": -1.5474, "fiftyDayAverageChangePercent": -0.273122, "twoHundredDayAverageChange": -2.408525, "twoHundredDayAverageChangePercent": -0.36902505, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "regularMarketChangePercent": 6.4134355, "regularMarketPrice": 4.1182, "marketState": "REGULAR", "longName": "Altimmune, Inc.", "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]